Quantcast

Latest Staphylococcus aureus Stories

2014-07-30 04:21:24

BILTHOVEN, the Netherlands, July 30, 2014 /PRNewswire/ -- Dutch market research panel 'hettestpanel.nl' tested Gladskin Skin Irritation on a large group of men and women suffering from skin irritation after shaving. Gladskin's scientific approach yields exceptionally high scores, with an 80% score on efficacy and 91% on user satisfaction. Gladskin Skin Irritation targets only the bacteria that cause or worsen the majority of all skin infections: Staphylococcus aureus....

2014-07-22 12:22:56

PITTSBURGH, July 22, 2014 /PRNewswire/ -- Hussey Copper, a leader in copper manufacturing and maker of MD-Cu(29) antimicrobial copper announces Pullman Regional Hospital's conversion of more than 1,100 touch points to the first EPA-registered antimicrobial solid touch surface, at a nominal cost. This reasonably priced surface kills greater than 99.9% of MRSA, E-coli and other bacteria within 2 hours of exposure(1) and will aid the hospital in protecting against bacteria and...

2014-07-20 23:00:24

Transparency Market Research published a new report "Global Hospital Infection Therapeutics Market: Industry Analysis, Size, Share, Growth and Forecast- 2018" to its report store. Browse the full report: http://www.transparencymarketresearch.com/hospital-infection-therapeutics.html Albany, New York (PRWEB) July 20, 2014 Hospital acquired infections are the infections acquired by the patients following the admission in hospitals within 48 hours. These conditions are also known as...

2014-07-07 12:28:56

To Effectively Compete with Current Anti-MRSA Therapies, Emerging Agents Will Need to be Amenable to Outpatient Use, According to Findings from Decision Resources Group BURLINGTON, Mass., July 7, 2014 /PRNewswire/ -- Decision Resources Group finds that, although vancomycin continues to be the standard-of-care for infections caused by methicillin-resistant Staphylococcus aureus (MRSA), there is growing concern among infectious disease (ID) specialists over rising vancomycin minimum inhibitory...

2014-07-01 08:30:44

SAN DIEGO, July 1, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that it has received two NIH small business grants which will fund the development of bispecific antibodies for two of its anti-bacterial immunotherapies. Sorrento's highly diverse, fully human G-MAB(®) library and proprietary antibody conjugation technology platforms have...

2014-06-24 08:31:01

Deal marks company's biggest deployment of groundbreaking healthcare worker safety enhancing uniforms ORLANDO, Fla., June 24, 2014 /PRNewswire/ -- Vestagen Technical Textiles, Inc. today announced it has finalized a five-year, multi-million dollar contract to provide Baptist Health of Jacksonville, Fla. with white coats and scrubs protected by Vestagen's proprietary Vestex(®) fabric. Vestex combines breathability, fluid-repellency and antimicrobial activity to reduce the risk of...

2014-06-12 08:29:09

FAIRFIELD, N.J., June 12, 2014 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. announced today that its licensor, Ferrer, has initiated the second Phase III clinical study for Ozenoxacin, a novel bactericidal non-fluorinated quinolone in development for impetigo. Ferrer, a privately-help Spanish pharmaceutical company, licensed US rights for Ozenoxacin to Medimetriks earlier this year. The multicenter, randomized, double-blinded, clinical study compares Ozenoxacin 1% cream...

2014-06-02 04:20:57

GLASGOW, Scotland, June 2, 2014 /PRNewswire/ -- MGB Biopharma, a biopharmaceutical company developing truly novel anti-infectives, announces today that Dr Stephanie Dancer, an internationally renowned medical microbiologist, has joined its scientific advisory board (SAB). She will help oversee the development of MGB Biopharma's lead antibiotic candidate, MGB-BP-3. An oral formulation of MGB-BP-3 is ready to enter Phase I development for Clostridium difficile, and an iv...

2014-05-28 12:23:42

As the dangers of the antibiotic-resistant bacteria known as MRSA, in addition to others, become more prevalent due to the overzealous use of antibiotics on livestock farms, Clearstream says that antimicrobial technologies and advanced long-term application protocols are part of the solution in containing the spread of viral and bacterial contaminants and protecting the public's health. HARRISBURG, N.C., May 28, 2014 /PRNewswire-iReach/ -- Studies have shown that farmworkers, as well as those...

Bacteria Can Remain On Airplane Surfaces For Days
2014-05-20 03:04:25

American Society for Microbiology Disease-causing bacteria can linger on surfaces commonly found in airplane cabins for days, even up to a week, according to research presented at the annual meeting of the American Society for Microbiology. "Many air travelers are concerned about the risks of catching a disease from other passengers given the long time spent in crowded air cabins," says Kiril Vaglenov, of Auburn University who presented the data. "This report describes the results of...


Latest Staphylococcus aureus Reference Libraries

72_eee8f4e550996ac6ae01af15eddb314c
2011-04-26 20:20:41

Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...

More Articles (1 articles) »
Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'